Aprea Therapeutics Inc (APRE)

May 03, 2026

APRE | Aprea Therapeutics, Inc. Common Executive Compensation - Quiver Quantitative

May 03, 2026

Apr 30, 2026

Reverse split and director votes in Aprea Therapeutics (NASDAQ: APRE) 2026 proxy - Stock Titan

Apr 30, 2026

Apr 30, 2026

[EFFECT] Aprea Therapeutics, Inc. SEC Filing - Stock Titan

Apr 30, 2026

Apr 29, 2026

74.35M shares registered for resale by Aprea Therapeutics (NASDAQ: APRE) - Stock Titan

Apr 29, 2026

Apr 28, 2026

CatalYm picks ex-Aprea CEO Christian Schade to chair board - Stock Titan

Apr 28, 2026

Apr 28, 2026

Aprea Abstract Accepted for ASCO on APR-1051 Phase 1 Study - MyChesCo

Apr 28, 2026

Apr 27, 2026

Aprea Therapeutics (NASDAQ: APRE) reporting group discloses 9.9% stake - Stock Titan

Apr 27, 2026

Apr 26, 2026

Two life sciences companies with Doylestown connections raise $119M - MSN

Apr 26, 2026

Apr 24, 2026

APRE Forecast, Price Target & Analyst Ratings | APREA THERAPEUTICS INC (NASDAQ:APRE) - ChartMill

Apr 24, 2026

Apr 23, 2026

Aprea (APRE): Buy, Sell, or Hold? | Q4 2025: EPS Beats ForecastsEV/EBITDA - Xã Vĩnh Công

Apr 23, 2026

Apr 22, 2026

Aprea Therapeutics (NASDAQ: APRE) registers 74.35M shares for resale by investors - Stock Titan

Apr 22, 2026

Apr 21, 2026

Aprea Therapeutics abstract accepted at ASCO meeting in May - Investing.com

Apr 21, 2026

Apr 21, 2026

Aprea Therapeutics abstract accepted at ASCO meeting in May By Investing.com - Investing.com Canada

Apr 21, 2026

Apr 21, 2026

Aprea Therapeutics Announces Acceptance of Abstract for Phase 1 Study of WEE1 Inhibitor APR-1051 at ASCO 2026 - Quiver Quantitative

Apr 21, 2026

Apr 21, 2026

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting - Weekly Voice

Apr 21, 2026

Apr 21, 2026

Early human data on Aprea cancer drug lands ASCO 2026 poster slot - Stock Titan

Apr 21, 2026

Apr 20, 2026

Aprea Therapeutics (NASDAQ: APRE) seeks board authority for 1‑for‑3–1‑for‑8 reverse split - Stock Titan

Apr 20, 2026

Apr 18, 2026

Aprea reports partial response in APR-1051 cancer trial - MSN

Apr 18, 2026

Apr 18, 2026

Aprea (APRE) Stock: Why It Matters Now (Eye on Rally) 2026-04-18Blue Chip Stocks - Xã Thanh Hà

Apr 18, 2026

Apr 17, 2026

Aprea reports 2025 results, early data for APR-1051 trial - MSN

Apr 17, 2026

Apr 17, 2026

Zentalis Surges 20% on WEE1 Inhibitor Dose Selection—But Is Aprea the Real Winner in This Space? - Barchart.com

Apr 17, 2026

Apr 17, 2026

10 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Apr 17, 2026

Apr 15, 2026

APRE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 15, 2026

Apr 14, 2026

3 Reasons to Avoid PTLO and 1 Stock to Buy Instead - Barchart.com

Apr 14, 2026

Apr 13, 2026

Analyst Calls: Is Aprea Therapeutics Inc stock a buy or sell2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Merger Talk: Is Aprea Therapeutics Inc affected by consumer sentimentWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

3 Reasons HUBG is Risky and 1 Stock to Buy Instead - Barchart.com

Apr 13, 2026

Apr 11, 2026

Aprea Therapeutics Showcases Emerging Clinical Data for WEE1 Inhibitor APR-1051 - Barchart

Apr 11, 2026

Apr 10, 2026

Aug Macro: How does Aprea Therapeutics Inc perform in inflationary periodsCPI Data & Precise Buy Zone Tips - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

What is the biggest uncertainty for Aprea (APRE) Stock | Price at $0.86, Up 17.17%Crowd Consensus Signals - Newser

Apr 10, 2026

Apr 09, 2026

APRE Breaks Key Resistance—But Bears Still Lurk Below - Bitget

Apr 09, 2026

Apr 09, 2026

Janus and Tecnoglass Shares Are Soaring, What You Need To Know - Barchart.com

Apr 09, 2026

Apr 09, 2026

Why Trex (TREX) Stock Is Up Today - Barchart.com

Apr 09, 2026

Apr 09, 2026

Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com

Apr 09, 2026

Apr 07, 2026

Simply Good Foods (SMPL) Reports Q1: Everything You Need To Know Ahead Of Earnings - Barchart.com

Apr 07, 2026

Apr 07, 2026

Aprea Therapeutics, Inc.Common Stock (NQ: APRE - FinancialContent

Apr 07, 2026

Apr 07, 2026

Squadron reports 1.27M warrant stake in Aprea Therapeutics (NASDAQ: APRE) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Aprea Reports Partial Response in APR-1051 Cancer Trial - MyChesCo

Apr 07, 2026

Apr 07, 2026

Why Apple (AAPL) Shares Are Falling Today - Barchart

Apr 07, 2026

Apr 06, 2026

Former Aprea CEO Christian Schade joins Frazier after Halda sale - Stock Titan

Apr 06, 2026

Apr 06, 2026

Here's What to Expect From 3M Company's Next Earnings Report - Barchart

Apr 06, 2026

Apr 04, 2026

APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

APRE Stock Analysis: Aprea Therapeutics Inc. Common Stock Up 1.65 Pct at 0.72 USD - Newser

Apr 03, 2026

Apr 02, 2026

Stocks in play: CGI Inc. - Barchart.com

Apr 02, 2026

Apr 02, 2026

APRE SEC FilingsAprea Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026